SLC1A5 and breast carcinoma: Similarly, l-γ-glutamyl-p-nitroanilide (GPNA), a potent ASCT2 inhibitor17, also sensitized breast cancer cells to MLN4924, as measured by both proliferation and clonogenic survival assays (Supplementary Fig. 8g–j).